Navigation Links
InspireMD Postpones $40 Million Registered
Date:11/16/2012

tified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of our existing and new products, (ii) negative clinical trial results or lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of our products, (iv) intense competition in the medical device industry from much larger, multi-national companies, (v) product liability claims, (vi) our limited manufacturing capabilities and reliance on subcontractors for assistance, (vii) insufficient or inadequate reimbursement by governmental and other third party payers for our products, (viii) our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful, (ix) legislative or regulatory reform of the healthcare system in both the U.S. and foreign jurisdictions, (x) our reliance on single suppliers for certain product components, (xi) the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain and (xii) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Transition Report on From 10-K/T and its Quarterly Reports on Form 10-Q.  Investors and security holders are urged to read these documents free of charge on the SEC's web site at
SOURCE InspireMD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
2. InspireMD Appoints Dr. James Barry to Its Board of Directors
3. InspireMD to Present at JMP Securities Healthcare Conferenceon July 12th in New York
4. InspireMD to Present at JMP Securities Healthcare Conference on July 12th in New York
5. InspireMD Reports 2012 Fiscal Year Results
6. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
7. Kansas Bioscience Authority Announces FY11 Outcomes of $207 Million
8. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
9. Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising
10. Radius Closes $27.65 Million Second Tranche of Previously Announced Financing
11. BioPower Systems Awarded $5 Million from Victorian Government
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... NESS ZIONA, Israel , September ... BVXV, TASE: BVXV) today announced the intent of the National ... U.S. National Institutes of Health (NIH) within the Department of ... 2 trial to be held in the United ... examine the use of BiondVax,s universal flu vaccine candidate, Multimeric-001 ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... will improve efficiency of their entire waste to energy process and continue to ... Gets a Major Upgrade , Temarry’s Waste to Energy process has been operating ...
(Date:9/1/2015)... South Carolina (PRWEB) , ... September 02, 2015 , ... ... has released new features to its eCommerce site Spirax Sarco Anytime. This platform, ... , Why wait to place your next order? Log on to Spirax Sarco ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... the new ImageXpress® Micro Confocal High-Content Imaging System. This transformative system fits ... use 3D cellular models such as spheroids, tissues, and organisms. , ...
Breaking Biology Technology:BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Temarry Recycling’s New $100,000 Waste to Energy Renovation 2Spirax Sarco Announces New Features to Anytime Platform 2ImageXpress Micro Confocal High-Content Imaging System Expands the Boundaries of Research 2ImageXpress Micro Confocal High-Content Imaging System Expands the Boundaries of Research 3
... Plastics are everywhere in our modern world, largely due ... but lightweight and easily workable. One of their most ... than break when put under stress - is also ... "plastic flow", allows many plastics to change shape to ...
... U.S. Pharmacopeial (USP) Convention is pleased to announce that Matthew Heyman ... integration on December 1, 2008. , ... Rockville, Md. ... is pleased to announce that Matthew Heyman joined the organization ...
... new way of thinking in integrated imaging , ... the European Society of Nuclear Medicine meeting in October ... demand in a time when the current economical situation demands maximum ... reaches the United States as a pioneer, not only in hybrid ...
Cached Biology Technology:Fast molecular rearrangements hold key to plastic's toughness 2Fast molecular rearrangements hold key to plastic's toughness 3USP Names Matthew Heyman Vice President of External Affairs and Strategic Integration 2USP Names Matthew Heyman Vice President of External Affairs and Strategic Integration 3Imaging in Living Color with Siemens Molecular CT 2Imaging in Living Color with Siemens Molecular CT 3Imaging in Living Color with Siemens Molecular CT 4
(Date:8/18/2015)... PRINCETON, N.J. , Aug. 18, 2015 ... be a key contributor to the Submission ... hosted by IRISS, a non-profit forum. Dedicated to ... IRISS provides a neutral platform for industry, ... to share information and work towards a ...
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions , ... entire spectrum of clinical research, is proud to announce ... company,s comprehensive SaaS-based eClinical technology platform, has led the ... first two quarters of 2015.   Q2 2015 and ... quarters measured by contract value sold in the company,s ...
(Date:8/12/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced that four of its fingerprint ID products, ... been named FIDO Certified™ by the Fast IDentity ... Synaptics, Natural ID™ fingerprint solutions are fully compliant ... standard and are interoperable among other products and ...
Breaking Biology News(10 mins):Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3MedNet Solutions Experiences Explosive Corporate Growth 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3
... food in northern Ghana difficult enough. It doesn,t help that ... to power tractors for planting crops or to power grain ... seeds from some native trees may be able to help. ... to create biodiesel from the seeds of trees that are ...
... the Exxon Valdez oil spill devastated a vast stretch of ... be unable to effectively manage a large oil spill, according ... 20th anniversary of the Exxon Valdez spill approaches on March ... offshore oil development in the Arctic until technologies improve to ...
... of Illinois plant geneticist Stephen Moose has developed a corn ... that would make good silage, Moose said, due to a ... make it a good energy crop. The gene known ... giving corn seedlings a waxy coating that acts like a ...
Cached Biology News:K-State researchers work with university in Ghana to create biofuels from native tree seeds 2Arctic governments and industry still unprepared for oil spills 20 years after Exxon Valdez 2Arctic governments and industry still unprepared for oil spills 20 years after Exxon Valdez 3Doubling a gene in corn results in giant biomass 2
... Immunogen: Partially purified ... MA1-710 detects vitamin D receptor (VDR) ... amphibian, and fish tissues. This ... or glucocorticoid receptors. MA1-710 detects ...
Unique enzyme blend containing Taq and Pwo DNA Polymerase and another thermostable enzyme. The Expand 20 kbPLUS PCR System also includes an optimized reaction buffer, MgCl2 solution, and a human cont...
... AccuPrime™ Pfx DNA Polymerase is ... fragments for downstream applications such as ... is provided by a proprietary enzyme ... Pyrococcus sp. with proofreading (3'Cut Site5' ...
... The EC105 power supply is a highly ... supply. A single adjustment knob and one hi-lo ... in 10 volt increments from 20 to 250 ... display from indicating output voltage to output current. ...
Biology Products: